Hmmm - let's see. Cantor Fitzgerald's analyst has just come out with a note, having read the docs, to say that not only does he think MSB will get approval, from what he's read, but approval without further any further trials required, for pediatric GVHD use. He thinks further trials will be required for use in adults (ie: which isn't what this trial was for) but not kids.
So, it seems like if people actually understood what the release said, that it was a positive not a negative, from how I've read Cantors note. Which makes todays selling very, very strange... But let's see.
Anyone else buy in after todays dip/crash?, page-85
-
- There are more pages in this discussion • 127 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |